CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope (Journal of Clinical Investigation (2008) 118, (3390-3402) DOI: 10.1172/JCI35449)

  1. Skowera, A.
  2. Ellis, R.J.
  3. Varela-Calviño, R.
  4. Arif, S.
  5. Guo, C.H.
  6. Van-Krinks, C.
  7. Zaremba, A.
  8. Rackham, C.
  9. Allen, J.S.
  10. Tree, T.I.M.
  11. Zhao, M.
  12. Dayan, C.M.
  13. Sewell, A.K.
  14. Unger, W.W.
  15. Drijfhout, J.W.
  16. Ossendorp, F.
  17. Roep, B.O.
  18. Peakman, M.
Revista:
Journal of Clinical Investigation

ISSN: 0021-9738,  1558-8238

Ano de publicación: 2009

Volume: 119

Número: 9

Páxinas: 2843

Tipo: Errata

DOI: 10.1172/JCI35449C1 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus